Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 23-Jan-23 4:21 PM View:  | Biotech Target N V 10% Owner | MacRogenics Inc (MGNX) | 19-Jan-23 | Private Purchase | 150,000 | $5.30 | $794,925.00 | 2% 8.93M to 9.08M | |
| 28-Dec-22 11:03 AM View: | Biotech Target N V 10% Owner | MacRogenics Inc (MGNX) | 27-Dec-22 | Purchase | 200,000 | $5.61 | $1,121,800.00 | 2% 8.73M to 8.93M | |
| 28-Dec-22 11:03 AM View: | Biotech Target N V 10% Owner | MacRogenics Inc (MGNX) | 23-Dec-22 | Private Purchase | 200,000 | $5.88 | $1,176,800.00 | 2% 8.53M to 8.73M | |
| 25-Nov-22 11:37 AM View: | Biotech Target N V 10% Owner | MacRogenics Inc (MGNX) | 22-Nov-22 | Private Purchase | 300,000 | $5.96 | $1,788,180.00 | 4% 8.23M to 8.53M | |
| 31-Oct-22 4:36 PM View: | Risser Eric Blasius Chief Operating Officer | MacRogenics Inc (MGNX) | 28-Oct-22 | Option Exercise | 8,500 | $1.51 | $12,835.00 | 19% 44.97K to 53.47K | |
| 25-Oct-22 4:19 PM View: | Biotech Target N V 10% Owner | MacRogenics Inc (MGNX) | 24-Oct-22 | Purchase | 250,000 | $4.36 | $1,090,500.00 | 3% 7.98M to 8.23M | |
| 25-Oct-22 4:19 PM View: | Biotech Target N V 10% Owner | MacRogenics Inc (MGNX) | 21-Oct-22 | Private Purchase | 250,000 | $4.63 | $1,157,100.00 | 3% 7.73M to 7.98M | |
| 21-Oct-22 3:03 PM View: | Biotech Target N V 10% Owner | MacRogenics Inc (MGNX) | 20-Oct-22 | Purchase | 285,977 | $4.00 | $1,143,560.00 | 4% 7.44M to 7.73M | |
| 21-Oct-22 3:03 PM View: | Biotech Target N V 10% Owner | MacRogenics Inc (MGNX) | 19-Oct-22 | Private Purchase | 168,422 | $3.70 | $623,919.00 | 2% 7.28M to 7.44M | |
| 17-Jun-22 4:18 PM View: | Karrels James SVP, CFO and Secretary | MacRogenics Inc (MGNX) | 15-Jun-22 | Private Purchase | 40,000 | $2.47 | $98,800.00 | 26% 151.78K to 191.78K | |
| 17-May-22 5:20 PM View: | Koenig Scott President and CEO Director | MacRogenics Inc (MGNX) | 16-May-22 | Option Exercise | 53,265 | $1.51 | $80,430.10 | 5% 996.38K to 1.05M | |
| 17-May-22 5:28 PM View: | Bonvini Ezio Sr VP, Research & CSO | MacRogenics Inc (MGNX) | 14-May-22 | Payment of Exercise | 1,666 | $4.16 | $6,930.56 | (1%) 116.09K to 114.42K | |
| 17-May-22 5:28 PM View: | Bonvini Ezio Sr VP, Research & CSO | MacRogenics Inc (MGNX) | 14-May-22 | Option Exercise | 5,000 | -- | -- | 5% 111.09K to 116.09K | |
| 28-Mar-22 4:56 PM View: | Karrels James SVP, CFO and Secretary | MacRogenics Inc (MGNX) | 28-Mar-22 | Option Exercise | 8,316 | $1.51 | $12,557.20 | 6% 143.46K to 151.78K | |
| 04-Mar-22 5:45 PM View: | Risser Eric Blasius Chief Operating Officer | MacRogenics Inc (MGNX) | 04-Mar-22 | Option Exercise | 500 | $0.94 | $470.00 | 1% 44.47K to 44.97K | |
| 23-Nov-21 12:29 PM View: | Biotech Target N V 10% Owner | MacRogenics Inc (MGNX) | 19-Nov-21 | Market Purchase | 200,000 | $18.50 | $3,700,320.00 | 3% 7.08M to 7.28M | (1%) |
| 16-Nov-21 5:30 PM View: | Bonvini Ezio Sr VP, Research & CSO | MacRogenics Inc (MGNX) | 16-Nov-21 | Option Exercise | 2,540 | $16.00 | $40,640.00 | 2% 108.55K to 111.09K | |
| 30-Sep-21 3:09 PM View: | Biotech Target N V 10% Owner | MacRogenics Inc (MGNX) | 29-Sep-21 | Market Purchase | 100,000 | $20.47 | $2,047,460.00 | 1% 6.98M to 7.08M | < 1% |
| 30-Sep-21 3:09 PM View: | Biotech Target N V 10% Owner | MacRogenics Inc (MGNX) | 28-Sep-21 | Market Purchase | 100,000 | $20.64 | $2,063,960.00 | 1% 6.88M to 6.98M | (< 1%) |
| 20-Sep-21 12:21 PM View: | Biotech Target N V 10% Owner | MacRogenics Inc (MGNX) | 17-Sep-21 | Market Purchase | 200,000 | $19.93 | $3,986,680.00 | 3% 6.68M to 6.88M | 3% |
| 20-Sep-21 12:21 PM View: | Biotech Target N V 10% Owner | MacRogenics Inc (MGNX) | 16-Sep-21 | Market Purchase | 400,000 | $20.94 | $8,376,800.00 | 6% 6.28M to 6.68M | (2%) |
| 20-Jul-21 5:09 PM View: | Spitznagel Thomas Sr VP, BPD & Manufacturing | MacRogenics Inc (MGNX) | 16-Jul-21 | Market Option Sale (Planned) | 5,000 | $25.01 | $125,050.00 | (100%) 5.0K to 0 | |
| 20-Jul-21 5:09 PM View: | Spitznagel Thomas Sr VP, BPD & Manufacturing | MacRogenics Inc (MGNX) | 16-Jul-21 | Option Exercise | 5,000 | $7.51 | $37,550.00 | 100% 0 to 5.0K | |
| 28-Jun-21 8:14 PM View: | Bonvini Ezio Sr VP, Research & CSO | MacRogenics Inc (MGNX) | 24-Jun-21 | Option Exercise | 26,076 | $16.73 | $436,337.00 | 32% 82.47K to 108.55K | |
| 23-Jun-21 1:33 PM View: | Biotech Target N V 10% Owner | MacRogenics Inc (MGNX) | 21-Jun-21 | Market Purchase | 75,000 | $21.74 | $1,630,170.00 | 1% 6.2M to 6.28M | 8% |
| 17-Jun-21 2:54 PM View: | Biotech Target N V 10% Owner | MacRogenics Inc (MGNX) | 16-Jun-21 | Market Purchase | 100,000 | $21.04 | $2,104,390.00 | 2% 6.1M to 6.2M | (< 1%) |
| 17-Jun-21 2:54 PM View: | Biotech Target N V 10% Owner | MacRogenics Inc (MGNX) | 15-Jun-21 | Market Purchase | 75,000 | $20.53 | $1,539,620.00 | 1% 6.03M to 6.1M | 2% |
| 18-May-21 5:06 PM View: | Bonvini Ezio Sr VP, Research & CSO | MacRogenics Inc (MGNX) | 14-May-21 | Payment of Exercise | 2,416 | $29.49 | $71,247.80 | (3%) 84.89K to 82.47K | |
| 18-May-21 5:06 PM View: | Bonvini Ezio Sr VP, Research & CSO | MacRogenics Inc (MGNX) | 14-May-21 | Option Exercise | 5,000 | -- | -- | 6% 79.89K to 84.89K | |
| 19-Apr-21 6:37 PM View: | Spitznagel Thomas Sr VP, BPD & Manufacturing | MacRogenics Inc (MGNX) | 15-Apr-21 | Option Exercise | 5,000 | $7.51 | $37,550.00 | 100% 0 to 5.0K | |
| 19-Apr-21 6:37 PM View: | Spitznagel Thomas Sr VP, BPD & Manufacturing | MacRogenics Inc (MGNX) | 15-Apr-21 | Market Option Sale (Planned) | 5,000 | $30.91 | $154,550.00 | (100%) 5.0K to 0 | |
| 24-Mar-21 5:07 PM View: | Karrels James SVP, CFO and Secretary | MacRogenics Inc (MGNX) | 22-Mar-21 | Market Sale (Planned) | 15,000 | $33.00 | $495,000.00 | (9%) 158.46K to 143.46K | 6% |
| 24-Mar-21 5:04 PM View: | Bonvini Ezio Sr VP, Research & CSO | MacRogenics Inc (MGNX) | 22-Mar-21 | Market Sale (Planned) | 3,917 | $32.00 | $125,344.00 | (5%) 83.81K to 79.89K | 3% |
| 09-Mar-21 7:55 PM View: | Peters Jeffrey Stuart General Counsel | MacRogenics Inc (MGNX) | 08-Mar-21 | Option Exercise | 21,749 | $11.50 | $250,114.00 | 100% 0 to 21.75K | |
| 09-Mar-21 7:55 PM View: | Peters Jeffrey Stuart General Counsel | MacRogenics Inc (MGNX) | 08-Mar-21 | Market Option Sale (Planned) | 21,749 | $26.50 | $576,348.00 | (100%) 21.75K to 0 | |
| 29-Jan-21 5:10 PM View: | Karrels James SVP, CFO and Secretary | MacRogenics Inc (MGNX) | 28-Jan-21 | Option Exercise | 6,000 | $1.41 | $8,490.00 | 4% 152.46K to 158.46K | |
| 30-Dec-20 4:05 PM View: | Risser Eric Blasius Sr VP & Chief Business Officer | MacRogenics Inc (MGNX) | 29-Dec-20 | Option Exercise | 500 | $1.51 | $755.00 | 1% 44.47K to 44.97K | |
| 30-Dec-20 4:05 PM View: | Risser Eric Blasius Sr VP & Chief Business Officer | MacRogenics Inc (MGNX) | 29-Dec-20 | Market Option Sale (Planned) | 500 | $24.10 | $12,050.00 | (1%) 44.97K to 44.47K | |
| 01-Dec-20 4:15 PM View: | Risser Eric Blasius Sr VP & Chief Business Officer | MacRogenics Inc (MGNX) | 30-Nov-20 | Option Exercise | 500 | $1.51 | $755.00 | 1% 44.47K to 44.97K | |
| 01-Dec-20 4:15 PM View: | Risser Eric Blasius Sr VP & Chief Business Officer | MacRogenics Inc (MGNX) | 30-Nov-20 | Market Option Sale (Planned) | 500 | $23.35 | $11,675.00 | (1%) 44.97K to 44.47K | (4%) |
| 29-Oct-20 7:52 PM View: | Risser Eric Blasius Sr VP & Chief Business Officer | MacRogenics Inc (MGNX) | 28-Oct-20 | Market Option Sale (Planned) | 1,500 | $20.69 | $31,035.00 | (3%) 45.97K to 44.47K | (17%) |
| 29-Oct-20 7:52 PM View: | Risser Eric Blasius Sr VP & Chief Business Officer | MacRogenics Inc (MGNX) | 28-Oct-20 | Option Exercise | 1,500 | $1.51 | $2,265.00 | 3% 44.47K to 45.97K | |
| 29-Sep-20 4:44 PM View: | Risser Eric Blasius Sr VP & Chief Business Officer | MacRogenics Inc (MGNX) | 28-Sep-20 | Option Exercise | 500 | $1.51 | $755.00 | 1% 44.47K to 44.97K | |
| 29-Sep-20 4:44 PM View: | Risser Eric Blasius Sr VP & Chief Business Officer | MacRogenics Inc (MGNX) | 28-Sep-20 | Market Option Sale (Planned) | 500 | $25.33 | $12,665.00 | (1%) 44.97K to 44.47K | 4% |
| 21-Sep-20 4:51 PM View: | Bonvini Ezio Sr VP, Research & CSO | MacRogenics Inc (MGNX) | 18-Sep-20 | Market Sale (Planned) | 18,339 | $32.00 | $586,848.00 | (18%) 102.15K to 83.81K | 24% |
| 21-Sep-20 4:51 PM View: | Bonvini Ezio Sr VP, Research & CSO | MacRogenics Inc (MGNX) | 17-Sep-20 | Market Sale (Planned) | 44,512 | $29.88 | $1,330,020.00 | (30%) 146.66K to 102.15K | 19% |
| 10-Sep-20 4:44 PM View: | Galbraith Kenneth Director | MacRogenics Inc (MGNX) | 09-Sep-20 | Option Exercise | 20,773 | $17.38 | $361,103.00 | 100% 0 to 20.77K | |
| 10-Sep-20 4:44 PM View: | Galbraith Kenneth Director | MacRogenics Inc (MGNX) | 09-Sep-20 | Market Option Sale | 20,773 | $27.11 | $563,156.00 | (100%) 20.77K to 0 | 10% |
| 27-Aug-20 5:04 PM View: | Risser Eric Blasius Sr VP & Chief Business Officer | MacRogenics Inc (MGNX) | 26-Aug-20 | Market Option Sale (Planned) | 500 | $27.10 | $13,549.50 | (1%) 44.97K to 44.47K | 10% |
| 27-Aug-20 5:04 PM View: | Risser Eric Blasius Sr VP & Chief Business Officer | MacRogenics Inc (MGNX) | 26-Aug-20 | Option Exercise | 500 | $1.51 | $755.00 | 1% 44.47K to 44.97K |
